Reporting of Immune Checkpoint Inhibitor Therapy-Associated Diabetes, 2015-2019

Jiaqing Liu; Huaqiang Zhou; Yaxiong Zhang; Wenfeng Fang; Yunpeng Yang; Yan Huang; Li Zhang

doi:10.2337/dc20-0459

Reporting of Immune Checkpoint Inhibitor Therapy-Associated Diabetes, 2015-2019

Diabetes Care. 2020 Jul;43(7):e79-e80. doi: 10.2337/dc20-0459. Epub 2020 May 11.

Authors

Jiaqing Liu^{1

2

3

4}, Huaqiang Zhou^{1

2

3}, Yaxiong Zhang^{1

2

3}, Wenfeng Fang^{1

2

3}, Yunpeng Yang^{1

2

3}, Yan Huang^{1

2

3}, Li Zhang^{5

2

3}

Affiliations

¹ Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
² State Key Laboratory of Oncology in South China, Guangzhou, China.
³ Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
⁴ Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
⁵ Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China zhangli6@mail.sysu.edu.cn.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't